Recommendations for Physical Activity: What Patients Want and What Practitioners Do

Physical activity has shown to be beneficial for patients with cancer, but are doctors recommending it enough? A team of researchers wanted to find out.
A recent focus group study found a disconnect between patient desire and practitioner action when it comes to physical activity recommendations. Physical activity can improve a patient’s sense of well-being, control, stress level and empowerment. It benefits both patients with early cancer who are receiving treatment of curative intent as well as patients in palliative care. The NCCN Clinical Practice Guidelines in Oncology for Survivorship currently recommend exercise for cancer survivors, too.

Researchers of the Gundersen Health System in Wisconsin surveyed 20 patients and nine practitioners on barriers to physical activities in patients with cancer for Are We on the Same Page? Patient and Provider Perceptions about Exercise in Cancer Care: A Focus Group Study, published in the Journal of the National Comprehensive Cancer Network.

Although 95 percent of patients surveyed felt that they benefited from exercise during treatment, only three of the 20 recalled being instructed to exercise. Likewise, while all practitioners noted the benefits of exercise to patients, only one of the nine practitioners surveyed documented discussion of exercise in the patient charts.
Agnes Smaradottir, M.D., lead researcher, stated, “Our results indicate that exercise is perceived as important to patients with cancer, both from a patient and physician perspective; however, physicians are reluctant to consistently include physical activity recommendations in their patient discussions. Our findings highlight the value of examining both patient and provider attitudes and behavioral intentions. While we uncovered barriers to exercise recommendations, questions remain on how to bridge the gap between patient and provider preferences.”

Patients also preferred to exercise at home, with 80 percent of those surveyed noting that they would rather be recommended a home-based exercise regimen so they could tailor it around their schedules and symptoms. Patients also noted that they would rather have their own oncologists give the recommendation, as they felt their oncologists best understand the complexities of their individual treatment plans.

It seems that the lack of recommendations from physicians stems from an uncertainty on the subject. Appropriate physical activity recommendations within a multimodal treatment plan is unclear. Additionally, physicians cite concern over a patient’s physical status and treatment plan as reasons for avoiding the recommendation of exercise. When treating patients who are receiving chemotherapy and radiation or who are frailer with limited mobility, patients cite concern over the patient’s physical condition as reasons for not approaching the topic of exercise.

The researchers recommend physician education as a solution to the disparity. A successful program, they feel, should include multidisciplinary collaboration that includes treating providers, physical therapy specialists, exercise pathologists and other relevant subspecialists. The education should also emphasize a patient-centered approach that favors individual recommendations specific to each patient’s treatment plan.

Smaradottir said, “Indeed, physicians, fellows and residents who collaborate with a PA specialist through a shared-care clinic visit will gain valuable education about how to discuss exercise recommendations with their patients.”

Crystal Denlinger, M.D., Chair of the NCCN Guidelines Panel for Survivorship, added, “This study highlights the discord between what we think is important and what we do in actual practice as providers. It also highlights patients’ desire to remain physically active and to receive guidance from their oncologists regarding what they can and should be doing. Based on the results of this and other studies, further work on both defining what the optimal physical activity recommendation for patients should be and determining how best to train our oncologic workforce to implement recommendations is needed.”

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Special Feature
Share Your Art
Related Articles
The Logistics of Multigene Panel Testing in Breast Cancer
Generally, health insurance covers the cost of genetic testing recommended by a physician. However, some patients who had BRCA testing in the past have had trouble getting reimbursed for a follow-up panel test. The outof- pocket cost for a single panel test can be up to $5,000, although lower-cost tests are available.
Young Patients With Cancer Don't Always Get the Info They Need
When treated for cancer, young patients don’t always get the information they need from doctors.
Immunotherapy Offers New Optimism for Patients With Merkel Cell Carcinoma
Although chemotherapy has been used to treat patients with Merkel cell carcinoma, immunotherapy agents show great promise, according to findings presented at the 2017 World Congress of Melanoma.
Related Videos
Preserving Eyebrows During Chemotherapy Treatment
Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.
Does Age Affect Cancer Genomics?
Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.  
Facing Advanced Cancer's Struggles With CALM
Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.
//For side ad protocol